These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37861978)

  • 1. Dual-energy CT improves differentiation of non-hypervascular pancreatic neuroendocrine neoplasms from CA 19-9-negative pancreatic ductal adenocarcinomas.
    Hu X; Shi S; Wang Y; Yuan J; Chen M; Wei L; Deng W; Feng ST; Peng Z; Luo Y
    Radiol Med; 2024 Jan; 129(1):1-13. PubMed ID: 37861978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Diagnosis of Nonhypervascular Pancreatic Neuroendocrine Neoplasms From Pancreatic Ductal Adenocarcinomas, Based on Computed Tomography Radiological Features and Texture Analysis.
    Yu H; Huang Z; Li M; Wei Y; Zhang L; Yang C; Zhang Y; Song B
    Acad Radiol; 2020 Mar; 27(3):332-341. PubMed ID: 31495760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
    Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
    Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Dual-Energy Computed Tomography for Detecting Small Pancreatic Ductal Adenocarcinoma.
    Fujisaki Y; Fukukura Y; Kumagae Y; Ejima F; Yamagishi R; Nakamura S; Kamizono J; Kurahara H; Hashimoto S; Yoshiura T
    Pancreas; 2022 Nov-Dec 01; 51(10):1352-1358. PubMed ID: 37099778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
    Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
    Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low keV portal venous phase as a surrogate for pancreatic phase in a pancreatic protocol dual-energy CT: feasibility, image quality, and lesion conspicuity.
    Noda Y; Tochigi T; Parakh A; Joseph E; Hahn PF; Kambadakone A
    Eur Radiol; 2021 Sep; 31(9):6898-6908. PubMed ID: 33744992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Quantitative Metrics From Dual-Layer Spectral-Detector CT for Differentiation of Pancreatic Neuroendocrine Tumor and Neuroendocrine Carcinoma.
    Wang Y; Hu X; Shi S; Song C; Wang L; Yuan J; Lin Z; Cai H; Feng ST; Luo Y
    AJR Am J Roentgenol; 2022 Jun; 218(6):999-1009. PubMed ID: 35043668
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
    Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
    Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma.
    Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nakajo M; Maemura K; Arima S; Yoshiura T
    Eur Radiol; 2020 Mar; 30(3):1679-1689. PubMed ID: 31728691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
    Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
    Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-energy computed tomography in a multiparametric regression model for diagnosing lymph node metastases in pancreatic ductal adenocarcinoma.
    Li S; Jiang D; Jiang L; Yan S; Liu L; Ruan G; Zhou X; Zhuo S
    Cancer Imaging; 2024 Mar; 24(1):38. PubMed ID: 38504330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
    Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
    Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic Neuroendocrine Neoplasms: CT Spectral Imaging in Grading.
    Li WX; Miao F; Xu XQ; Zhang J; Wu ZY; Chen KM; Yan FH; Lin XZ
    Acad Radiol; 2021 Feb; 28(2):208-216. PubMed ID: 32111466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of duodenal gastrointestinal stromal tumors from hypervascular pancreatic neuroendocrine tumors in the pancreatic head using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang J; Zhao R; Song L; Li H; Wang Z
    Abdom Radiol (NY); 2019 Mar; 44(3):867-876. PubMed ID: 30293109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of quantitative dual-energy computed tomography iodine maps and abdominal computed tomography perfusion measurements: are single-acquisition dual-energy computed tomography iodine maps more than a reduced-dose surrogate of conventional computed tomography perfusion?
    Stiller W; Skornitzke S; Fritz F; Klauss M; Hansen J; Pahn G; Grenacher L; Kauczor HU
    Invest Radiol; 2015 Oct; 50(10):703-8. PubMed ID: 26039774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simulated twin-phase pancreatic CT generated using single portal venous phase dual-energy CT acquisition in pancreatic ductal adenocarcinoma.
    Noda Y; Tochigi T; Parakh A; Kambadakone A
    Abdom Radiol (NY); 2021 Jun; 46(6):2610-2619. PubMed ID: 33454806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT.
    Kaltenbach B; Wichmann JL; Pfeifer S; Albrecht MH; Booz C; Lenga L; Hammerstingl R; D'Angelo T; Vogl TJ; Martin SS
    Eur J Radiol; 2018 Aug; 105():20-24. PubMed ID: 30017280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
    Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
    AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
    [No Abstract]   [Full Text] [Related]  

  • 20. Iodine concentration and tissue attenuation in dual-energy contrast-enhanced CT as a potential quantitative parameter in early detection of local pancreatic carcinoma recurrence after surgical resection.
    Mathy RM; Fritz F; Mayer P; Klauss M; Grenacher L; Stiller W; Kauczor HU; Skornitzke S
    Eur J Radiol; 2021 Oct; 143():109944. PubMed ID: 34482176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.